Neurology 910 - Neurology Alert - Oct 01, 2005

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Fred Plum, MD
University Professor;
Department of Neurology;
Cornell University Medical College

M. Flint Beal, MD
Professor and Chairman
Department of Neurology
Cornell University Medical College
New York, NY

Assistant Editors
Claire Henchcliffe, MD, DPhil
Assistant Professor
Department of Neurology
Weill Medical College
Cornell University

Matthew Fink, MD
Vice Chairman
Professor of Clinical Neurology
Weill Medical College
Division of Stroke and Critical Care Neurology
New York Presbyterian Hospital

Michael Rubin, MD
Professor of Clinical Neurology
New York-Presbyterian Hospital
Cornell Campus

Charles P. Pollack, MD
Clinical Neurology
Weill College of Medicine


  • Increased Dietary Intake of Folate Reduces the Risk of Developing Alzheimer's Disease
  • Imaging Depression in Parkinson's Disease: Role of the Limbic System
  • A Step Towards Restorative Therapy in Parkinson's Disease
  • Clipping vs Coiling for Ruptured Intracranial Aneurysms
  • Sleepwalking: More Often Neurological Than Psychiatric
  • Review: HIV and Myopathy


  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present "basic science? lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert’s physician editors, Fred Plum, MD and M. Flint Beal, MD, and assistant editor, Matthew Fink, MD, report no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study.

Claire Henchcliffe, MD, DPhil is on the speaker’s bureau for GlaxoSmithKline, Teva/Eisai, and Boehringer Ingelheim.

Charles P. Pollack, MD is a stockholder and on the speaker’s bureau for Cephalon.

Michael Rubin, MD is on the speaker’s bureau for Athena Diagnostics, and does research for Pfizer and Merck.

Copyright 2005 AHC Media. All rights reserved.